title: Nuclear medicine imaging studies in the diagnosis of head and neck disease.
abstract: Nuclear medicine studies have a role in the evaluation of drug induced osteonecrosis of the jaw (DIONJ). In this article, we discuss the current and future applications within nuclear medicine appropriate for evaluation of DIONJ. The emphasis of this article is positron emission tomography (PET) imaging, specifically, with 18F-fluoro-deoxy-glucose (FDG).
authors.affiliation: Radiology, The Methodist Hospital, 6565 Fannin Street, Houston, TX 77030, USA. Electronic address: sbchiang@tmhs.org.
authors.forename: Steve
authors.initials: S
authors.lastname: Chiang
mesh_terms: D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000000981:diagnostic imaging*; D019788:Fluorodeoxyglucose F18; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging*; D006801:Humans; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: Drug-induced osteonecrosis of the jaw (DIONJ); FDG; Nuclear medicine imaging; PET/CT